+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personalized Medicine In Oncology"

From
From
From
From
Radioligand Therapeutics in Cancer Treatment: Global Markets - Product Thumbnail Image

Radioligand Therapeutics in Cancer Treatment: Global Markets

  • Report
  • February 2026
  • 106 Pages
  • Global
From
Biosimulation Market (2025 Edition) - Product Thumbnail Image

Biosimulation Market (2025 Edition)

  • Report
  • December 2025
  • 241 Pages
  • Global
From
From
From
U.S. Bispecific Antibodies Market Forecast to 2033 - Product Thumbnail Image

U.S. Bispecific Antibodies Market Forecast to 2033

  • Report
  • October 2025
  • 100 Pages
  • United States
From
From
From
From
From
From
From
From
Melanoma Cancer Market in the United States - Product Thumbnail Image

Melanoma Cancer Market in the United States

  • Report
  • May 2026
  • 170 Pages
  • United States
From
Thymus Cancer Market in the United States - Product Thumbnail Image

Thymus Cancer Market in the United States

  • Report
  • April 2026
  • 257 Pages
  • United States
From
Loading Indicator

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient. Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more